Low-cost biomarkers using routinely available blood tests are used to make treatment decisions for patients with hepatitis B. How well do these work in Africa, where over 80 million people are living with chronic infection?
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us